As of April 16, 2025, Santen Pharmaceutical (4536.T) has a market cap of $3.27 billion USD. According to our data, Santen Pharmaceutical is ranked No.3224 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $3.27 B |
-15.71%
|
Dec 30, 2024 | $3.88 B |
17.60%
|
Dec 29, 2023 | $3.30 B |
34.19%
|
Dec 30, 2022 | $2.46 B |
-21.42%
|
Dec 30, 2021 | $3.13 B |
-14.37%
|
Dec 30, 2020 | $3.66 B |
-18.59%
|
Dec 30, 2019 | $4.49 B |
33.46%
|
Dec 31, 2018 | $3.36 B |
-9.10%
|
Dec 29, 2017 | $3.70 B |
25.73%
|
Dec 30, 2016 | $2.94 B |
-27.56%
|
Dec 30, 2015 | $4.06 B |
57.23%
|
Dec 30, 2014 | $2.58 B |
34.53%
|
Dec 30, 2013 | $1.92 B |
52.16%
|
Dec 28, 2012 | $1.26 B |
7.25%
|
Dec 30, 2011 | $1.18 B |
15.46%
|
Dec 30, 2010 | $1.02 B |
-1.41%
|
Dec 30, 2009 | $1.03 B |
11.64%
|
Dec 30, 2008 | $0.93 B |
1.82%
|
Dec 28, 2007 | $0.91 B |
-15.96%
|
Dec 29, 2006 | $1.08 B |
7.38%
|
Dec 30, 2005 | $1.01 B |
45.51%
|
Dec 31, 2004 | $0.69 B |
62.04%
|
Dec 31, 2003 | $0.43 B |
31.59%
|
Dec 31, 2002 | $0.32 B |
-25.13%
|
Dec 31, 2001 | $0.43 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Alcon
ALC
|
$45.22 B |
-0.002 M
|
![]() Switzerland
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
![]() Israel
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
Market Cap | = | 4536.T Stock Price | * | 4536.T Shares Outstanding |
= | $9.58 | * | 0.34 B | |
= | $3.27 B |